<DOC>
	<DOC>NCT03003481</DOC>
	<brief_summary>Collect patient data and to monitor the clinical use (safety and efficacy) of the device</brief_summary>
	<brief_title>Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech PLD Device</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: Patients with PVL associated hemolysis, recurrent blood transfusions, or hemodynamically significant heart failure Exclusion criteria The device is contraindicated for patients known to have any of the following: Known coagulation dysfunction Leak reversal with separate or significant residual or recurrent leak Acute infection Known intracardiac thrombi Recent pelvic venous thrombosis Recent myocardial infarction or a surgical bypass operation in the last 30 days If adequate oral anticoagulation therapy / antiplatelet aggregation inhibition is not possible postprocedurally Intolerance of contrast agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>